Clinical Trials Logo
  1. Home
  2. Carcinoma, Ductal, Breast
  3. NCT02576106

Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy — CRYOSE01  

Carcinoma, Ductal, Breast Clinical Trial

Official title:
Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy

Clinical Trial Summary

The primary objective of this monocentric and feasibility study is to review the efficacy of cryotherapy in the treatment of unifocal mammary carcinomas in post-menopausal patients, with lumpectomy indication. The efficacy is defined by the rate of success of cryotherapy procedures. For each one of those evaluated process, an success will be defined on the tumor sample of lumpectomy by the absence of viable tumour cells. On the basis of our expertise, it seems interesting to propose this experimental procedure to patients as described above.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02576106
Study type Interventional
Source Centre Leon Berard
Contact
Status Completed
Phase N/A
Start date February 2016
Completion date January 2020
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01891357 - Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer Phase 2
Completed NCT03455270 - G1T48, an Oral SERD, Alone and in Combination With Palbociclib in ER-Positive, HER2-Negative Advanced Breast Cancer Phase 1
Completed NCT01508546 - Conservative Surgery With or Without Axillary Lymphnode Removal in Treating Women With T1N0 Breast Cancer Phase 3
Completed NCT00616135 - Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy Phase 4
Active, not recruiting NCT00470236 - Radiation Doses and Fractionation Schedules in Non-low Risk Ductal Carcinoma In Situ (DCIS) of the Breast N/A
Completed NCT03113825 - Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery Phase 2
Completed NCT04498611 - Prediction of Upgrade to Invasive Cancer in Patients Diagnosed With Ductal Carcinoma in Situ by Percutaneous Core Needle Biopsy N/A
Active, not recruiting NCT02983071 - G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Phase 1/Phase 2
Withdrawn NCT02610920 - Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection Early Phase 1